0001104659-23-107217.txt : 20231005 0001104659-23-107217.hdr.sgml : 20231005 20231005164146 ACCESSION NUMBER: 0001104659-23-107217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231003 FILED AS OF DATE: 20231005 DATE AS OF CHANGE: 20231005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PFREUNDSCHUH PETER P. CENTRAL INDEX KEY: 0001585839 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37625 FILM NUMBER: 231311853 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS, INC. STREET 2: 300 THE AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Voyager Therapeutics, Inc. CENTRAL INDEX KEY: 0001640266 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-5340 MAIL ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 tm2327817-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-03 0 0001640266 Voyager Therapeutics, Inc. VYGR 0001585839 PFREUNDSCHUH PETER P. C/O VOYAGER THERAPEUTICS, INC., 64 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-10-03 4 S 0 13567 6.99 D 149433 D Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 1, 2023. The sales do not represent a discretionary trade by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ Scott MacDonald, as Attorney-in-Fact for Peter P. Pfreundschuh 2023-10-05